KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) Liabilities from Discontinued Operations (2016)

Abbott Laboratories' Liabilities from Discontinued Operations history spans 5 years, with the latest figure at 245000000.0 for Q4 2016.

  • For Q4 2016, Liabilities from Discontinued Operations fell 34.32% year-over-year to 245000000.0; the TTM value through Dec 2016 reached 245000000.0, down 34.32%, while the annual FY2016 figure was 245000000.0, 34.32% down from the prior year.
  • Liabilities from Discontinued Operations for Q4 2016 was 245000000.0 at Abbott Laboratories, down from 373000000.0 in the prior quarter.
  • Across five years, Liabilities from Discontinued Operations topped out at 680000000.0 in Q4 2014 and bottomed at 1000000.0 in Q1 2014.
  • The 4-year median for Liabilities from Discontinued Operations is 269539000.0 (2013), against an average of 231749153.85.
  • The largest annual shift saw Liabilities from Discontinued Operations tumbled 99.63% in 2014 before it surged 30000.0% in 2015.
  • A 4-year view of Liabilities from Discontinued Operations shows it stood at 386000000.0 in 2013, then surged by 76.17% to 680000000.0 in 2014, then tumbled by 45.15% to 373000000.0 in 2015, then crashed by 34.32% to 245000000.0 in 2016.
  • Per Business Quant, the three most recent readings for ABT's Liabilities from Discontinued Operations are 245000000.0 (Q4 2016), 373000000.0 (Q4 2015), and 356000000.0 (Q3 2015).